Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
$9.52
+0.6%
$9.66
$5.47
$13.50
$386.58M0.52562,820 shs467,802 shs
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
$10.56
+3.2%
$10.38
$4.88
$13.79
$1.52B1.22.04 million shs2.29 million shs
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$15.83
+0.5%
$21.30
$15.46
$32.66
$1.22B1.241.05 million shs429,645 shs
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
$13.03
+0.5%
$16.25
$12.08
$20.73
$508.46M0.99258,661 shs245,828 shs

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
+0.63%+3.03%+0.85%-23.41%+50.39%
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
+3.23%+10.81%+13.06%-8.73%-15.59%
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
+0.51%-9.13%-30.02%-34.32%-50.44%
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
+0.54%-6.39%-21.51%-28.13%+0.23%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
4.1435 of 5 stars
3.53.00.04.23.51.70.6
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
4.0134 of 5 stars
3.41.00.03.33.14.20.6
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
4.2511 of 5 stars
2.93.00.04.02.41.72.5
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
2.9021 of 5 stars
3.43.00.00.02.22.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
3.00
Buy$14.0047.06% Upside
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
2.89
Moderate Buy$17.6767.30% Upside
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
1.89
Reduce$22.7143.49% Upside
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
2.80
Moderate Buy$23.3379.07% Upside

Current Analyst Ratings Breakdown

Latest ANGO, ATEC, IART, and OFIX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/14/2025
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$20.00 ➝ $20.00
4/11/2025
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$26.00 ➝ $19.00
4/7/2025
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$15.00 ➝ $16.00
3/31/2025
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy
2/27/2025
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$12.00 ➝ $13.00
2/27/2025
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$16.00 ➝ $16.00
2/26/2025
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$24.00 ➝ $24.00
2/26/2025
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$22.00 ➝ $22.00
1/22/2025
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$20.00 ➝ $21.00
1/22/2025
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$24.00
(Data available from 4/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
$283.32M1.36$3.95 per share2.41$5.13 per share1.86
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
$611.56M2.49N/AN/A$0.57 per share18.53
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$1.61B0.76$3.47 per share4.56$20.31 per share0.78
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
$799.49M0.64N/AN/A$16.11 per share0.81
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
-$184.35M-$1.01N/AN/AN/A-79.38%-7.26%-4.78%N/A
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
-$186.64M-$1.14N/AN/AN/A-31.06%-541.39%-22.99%5/1/2025 (Estimated)
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$67.74M-$0.09N/A6.330.73-0.42%12.35%4.82%5/5/2025 (Estimated)
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
-$151.40M-$3.29N/AN/AN/A-15.18%-21.25%-13.29%5/6/2025 (Estimated)

Latest ANGO, ATEC, IART, and OFIX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2025Q1 2025
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
-$0.17N/AN/AN/A$191.10 millionN/A
5/5/2025Q1 2025
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$0.43N/AN/AN/A$381.17 millionN/A
5/1/2025Q1 2025
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
-$0.12N/AN/AN/A$167.57 millionN/A
4/2/2025Q3 2025
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
-$0.13$0.03+$0.16-$0.11$70.30 million$72.00 million
2/26/2025Q4 2024
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
-$0.19-$0.23-$0.04-$0.23$172.74 million$176.79 million
2/25/2025Q4 2024
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$0.85$0.97+$0.12$0.25$445.15 million$442.65 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
N/AN/AN/AN/AN/A
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
N/AN/AN/AN/AN/A
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
N/AN/AN/AN/AN/A
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
N/A
1.98
1.24
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
30.21
2.32
1.15
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
0.79
1.20
0.73
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
0.25
2.39
1.11

Institutional Ownership

CompanyInstitutional Ownership
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
89.43%
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
66.35%
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
84.78%
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
89.76%

Insider Ownership

CompanyInsider Ownership
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
5.40%
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
22.80%
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
3.10%
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
2.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
76040.61 million38.28 millionOptionable
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
700144.15 million109.48 millionOptionable
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
3,72077.22 million74.77 millionOptionable
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
1,09039.02 million37.22 millionOptionable

Recent News About These Companies

Orthofix to Report First Quarter 2025 Financial Results
5 medtech notes: Orthofix, Tenon Medical and more
Orthofix Medical Inc

New MarketBeat Followers Over Time

Media Sentiment Over Time

AngioDynamics stock logo

AngioDynamics NASDAQ:ANGO

$9.52 +0.06 (+0.63%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$9.86 +0.34 (+3.61%)
As of 04/17/2025 05:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.

Alphatec stock logo

Alphatec NASDAQ:ATEC

$10.56 +0.33 (+3.23%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$10.56 0.00 (0.00%)
As of 04/17/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

Integra LifeSciences stock logo

Integra LifeSciences NASDAQ:IART

$15.83 +0.08 (+0.51%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$15.87 +0.04 (+0.25%)
As of 04/17/2025 05:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Orthofix Medical stock logo

Orthofix Medical NASDAQ:OFIX

$13.03 +0.07 (+0.54%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$13.03 0.00 (0.00%)
As of 04/17/2025 04:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.